The vast majority of studies describing a ‘dying-back’ axonopathy mechanism in ALS are based on mutant SOD1 models (15,16,19) and relatively little is known about disease mechanisms for FUS-linked ALS and FTLD. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.